• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从成功预防老年糖尿病患者终末期肾病中估计预期寿命的节省:来自台湾的全国性研究。

Estimation of expected life-years saved from successful prevention of end-stage renal disease in elderly patients with diabetes: a nationwide study from Taiwan.

机构信息

Division of Geriatrics and Gerontology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

出版信息

Diabetes Care. 2012 Nov;35(11):2279-85. doi: 10.2337/dc12-0545. Epub 2012 Aug 8.

DOI:10.2337/dc12-0545
PMID:22875232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3476928/
Abstract

OBJECTIVE

Because of the increasing incidence and prevalence of diabetes as a leading cause of end-stage renal disease (ESRD) in the aging population, we estimated the expected life-years (LYs) saved from successful prevention of ESRD in elderly patients with diabetes.

RESEARCH DESIGN AND METHODS

We conducted a population-based cohort study using the National Health Insurance Research Database. We identified all incidences of ESRD in the individuals >65 years of age who were receiving maintenance hemodialysis (N = 24,243) from the registry files of catastrophic illnesses in Taiwan from 1 July 1997 to 31 December 2005. We then retrospectively searched the database to determine whether there had been a diagnosis of diabetes in these cases. After the exclusion of individuals with malignancy (n = 3,423), we extrapolated the survival rates through the end of 2006 using the Monte Carlo method. Using the data of preventable ESRD cases due to diabetes and expected years of life lost (EYLL) in each age stratum, we further estimated the expected LYs saved from successful prevention of ESRD in elderly patients with diabetes.

RESULTS

The estimated average EYLL was 10.6-5.8 and 12.3-7.3 years for diabetic males and females, respectively, aged 65-79 years. In total, 5,430.1 LYs and 10,177 LYs could be saved by the successful prevention of ESRD in male and female elderly patients with diabetes, respectively, in a single year.

CONCLUSIONS

The LYs saved by successful prevention of ESRD in elderly patients with diabetes in a single year are substantial and deserve special attention, especially in elderly females.

摘要

目的

由于糖尿病作为老龄化人口中终末期肾病(ESRD)的主要病因,其发病率和患病率不断增加,我们估算了成功预防老年糖尿病患者 ESRD 所节省的预期寿命(LY)。

研究设计和方法

我们使用全民健康保险研究数据库进行了一项基于人群的队列研究。我们从台湾灾难性疾病登记档案中确定了 1997 年 7 月 1 日至 2005 年 12 月 31 日期间接受维持性血液透析的 65 岁以上人群中所有 ESRD 的发病率(N=24243)。然后,我们从数据库中回溯性地确定这些病例是否有糖尿病诊断。排除恶性肿瘤患者(n=3423)后,我们使用蒙特卡罗法推断截至 2006 年底的生存率。利用每个年龄组中因糖尿病可预防的 ESRD 病例数和预期寿命损失(EYLL)数据,我们进一步估算了成功预防老年糖尿病患者 ESRD 所节省的预期 LY。

结果

65-79 岁的男性和女性糖尿病患者的平均 EYLL 分别估计为 10.6-5.8 和 12.3-7.3 年。在一年内,成功预防老年男性和女性糖尿病患者的 ESRD 可分别节省 5430.1 和 10177 LY。

结论

成功预防老年糖尿病患者 ESRD 可在一年内节省大量的 LY,值得特别关注,尤其是老年女性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e327/3476928/2807c884f2ca/2279fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e327/3476928/2807c884f2ca/2279fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e327/3476928/2807c884f2ca/2279fig1.jpg

相似文献

1
Estimation of expected life-years saved from successful prevention of end-stage renal disease in elderly patients with diabetes: a nationwide study from Taiwan.从成功预防老年糖尿病患者终末期肾病中估计预期寿命的节省:来自台湾的全国性研究。
Diabetes Care. 2012 Nov;35(11):2279-85. doi: 10.2337/dc12-0545. Epub 2012 Aug 8.
2
Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).澳大利亚和新西兰(1991 - 2005年)终末期肾病患者按糖尿病状态划分的发病率、治疗情况、预后及性别对生存的影响
Diabetes Care. 2007 Dec;30(12):3070-6. doi: 10.2337/dc07-0895. Epub 2007 Sep 11.
3
Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study.中药使用与糖尿病肾病患者的终末期肾病和死亡率降低相关:一项基于人群的队列研究。
BMC Complement Altern Med. 2019 Apr 3;19(1):81. doi: 10.1186/s12906-019-2491-y.
4
The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.糖尿病对德国终末期肾病发病率和死亡率的影响。
Nephrol Dial Transplant. 2011 May;26(5):1634-40. doi: 10.1093/ndt/gfq609. Epub 2010 Oct 19.
5
Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.1990年至2001年台湾地区透析终末期肾病的发病率、患病率及死亡率趋势:国民健康保险的影响
Nephrol Dial Transplant. 2008 Dec;23(12):3977-82. doi: 10.1093/ndt/gfn406. Epub 2008 Jul 15.
6
Diabetic end-stage renal disease among Native Americans.美国原住民中的糖尿病终末期肾病
Diabetes Care. 1993 Jan;16(1):346-8. doi: 10.2337/diacare.16.1.346.
7
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.糖尿病患者终末期肾病的风险:对参加多重危险因素干预试验(MRFIT)筛查的男性进行的一项前瞻性队列研究。
JAMA. 1997 Dec 17;278(23):2069-74.
8
Changing trends in end-stage renal disease patients with diabetes.糖尿病终末期肾病患者的变化趋势
Swiss Med Wkly. 2017 Jul 6;147:w14458. doi: 10.4414/smw.2017.14458. eCollection 2017.
9
Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study.儿童期发病的1型糖尿病发病年龄与终末期肾病的发生:一项基于全国人口的研究。
Diabetes Care. 2006 Mar;29(3):538-42. doi: 10.2337/diacare.29.03.06.dc05-1531.
10
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.蛋白尿 2 型糖尿病和肾病患者发生终末期肾病与心血管死亡率的相对发生率:来自 DIAMETRIC(糖尿病肾脏并发症防治研究联盟)数据库的结果。
Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.

引用本文的文献

1
Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends.韩国老年糖尿病患者:最新临床与流行病学趋势
Diabetes Metab J. 2025 Mar;49(2):183-193. doi: 10.4093/dmj.2024.0836. Epub 2025 Mar 1.
2
Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂对糖尿病患者主要肾脏结局的比较疗效:一项15年队列研究。
PLoS One. 2017 May 15;12(5):e0177654. doi: 10.1371/journal.pone.0177654. eCollection 2017.
3
Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score.

本文引用的文献

1
Diabetes mellitus: prevalence and effect of morbidities in the oldest old. The Octabaix study.糖尿病:超高龄人群中的患病率和并发症影响。Octabaix 研究。
J Am Geriatr Soc. 2012 Mar;60(3):462-7. doi: 10.1111/j.1532-5415.2011.03835.x. Epub 2012 Feb 8.
2
Standards of medical care in diabetes--2012.《糖尿病医疗护理标准——2012》
Diabetes Care. 2012 Jan;35 Suppl 1(Suppl 1):S11-63. doi: 10.2337/dc12-s011.
3
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
血液透析和腹膜透析的成本效益:一项长达14年随访且根据合并症和倾向评分进行匹配的全国队列研究。
Sci Rep. 2016 Jul 27;6:30266. doi: 10.1038/srep30266.
4
Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.台湾地区绩效薪酬对糖尿病患者死亡率的影响:一项基于人群的研究。
Medicine (Baltimore). 2016 Jul;95(27):e4197. doi: 10.1097/MD.0000000000004197.
5
Quality of life in polyneuropathy: association with biomarkers of small fiber impairment.多发性神经病患者的生活质量:与小纤维损伤生物标志物的关联
Health Qual Life Outcomes. 2015 Oct 15;13:169. doi: 10.1186/s12955-015-0363-9.
6
Estimation of physical functional disabilities and long-term care needs for patients under maintenance hemodialysis.维持性血液透析患者躯体功能障碍及长期照护需求评估。
Med Care. 2014 Jan;52(1):63-70. doi: 10.1097/MLR.0000000000000010.
《美国肾脏数据系统2011年年报:美国慢性肾脏病与终末期肾病地图集》
Am J Kidney Dis. 2012 Jan;59(1 Suppl 1):A7, e1-420. doi: 10.1053/j.ajkd.2011.11.015.
4
Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy.老年 5 期 CKD 患者的生存:保守治疗与肾脏替代治疗的比较。
Nephrol Dial Transplant. 2011 May;26(5):1608-14. doi: 10.1093/ndt/gfq630. Epub 2010 Nov 22.
5
Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.台湾地区慢性肾脏病的流行病学、影响因素与预防保健。
Nephrology (Carlton). 2010 Jun;15 Suppl 2:3-9. doi: 10.1111/j.1440-1797.2010.01304.x.
6
Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients.血液透析和腹膜透析患者的预期寿命、预期寿命损失年数和生存率。
J Nephrol. 2010 Nov-Dec;23(6):677-82.
7
The global burden of diabetes and its complications: an emerging pandemic.糖尿病及其并发症的全球负担:一场新出现的大流行。
Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S3-8. doi: 10.1097/01.hjr.0000368191.86614.5a.
8
Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006.糖尿病、合并症及 A1C 与老年人功能障碍的关联:来自 1999-2006 年全国健康和营养调查(NHANES)的结果。
Diabetes Care. 2010 May;33(5):1055-60. doi: 10.2337/dc09-1597. Epub 2010 Feb 25.
9
Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.与服用含木通或防己的草药产品相关的肾衰竭风险:一项基于人群的病例对照研究。
Am J Kidney Dis. 2010 Mar;55(3):507-18. doi: 10.1053/j.ajkd.2009.10.055. Epub 2010 Feb 8.
10
Management of type 2 diabetes: NICE guidelines.2型糖尿病的管理:英国国家卫生与临床优化研究所指南
Clin Med (Lond). 2009 Aug;9(4):353-7. doi: 10.7861/clinmedicine.9-4-353.